Sign In
Buy WBA
$11.98
+0 (+0%)
At Close: Nov 26, 2025
Walgreens Boots CEO: We will beat Amazon because of our 'human interface' for customers
07:25pm, Thursday, 28'th Mar 2024
Walgreens Boots Alliance CEO Tim Wentworth sits down with 'Mad Money' host Jim Cramer to discuss the company's plan to innovate, competition from Amazon and the retail shrink problem.
Walgreens Boots Alliance CEO Tim Wentworth goes one-on-one with Jim Cramer
07:22pm, Thursday, 28'th Mar 2024
Walgreens Boots Alliance CEO Tim Wentworth sits down with 'Mad Money' host Jim Cramer to discuss the company's plan to innovate, competition from Amazon and the retail shrink problem.
7 Blue-Chip Stocks to Buy at a 52-Week Low in March
06:45pm, Thursday, 28'th Mar 2024
If you're searching for cheap blue-chip stocks to buy, look no further. Blue-chip stocks continue to lag the performance of growth stocks.
Why Walgreens Boots Alliance Stock Trounced the Market Today
04:39pm, Thursday, 28'th Mar 2024
The pharmacy chain operator published its latest set of quarterly results. These results showed growth on both the top and bottom lines.
Walgreens aims to deliver value as consumers seek relief: CEO
04:30pm, Thursday, 28'th Mar 2024
Despite beating analyst expectations on both revenue and earnings in its latest second quarter results, Walgreens Boots Alliance (WBA) narrowed its Adjusted EPS guidance for fiscal year 2024, citing a
Walgreens Taps Personalized Marketing to Reach Deal-Seeking Consumers
03:31pm, Thursday, 28'th Mar 2024
As economic pressures weigh on shoppers' minds, Walgreens is leveraging its targeting capabilities to keep them engaged. On a call with analysts Thursday (March 28) discussing second-quarter fiscal 20
Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending
03:04pm, Thursday, 28'th Mar 2024
Walgreens Boots Alliance narrowed its fiscal 2024 guidance citing a challenging retail environment, including reduced consumer spending, and the chain is on track for $1 billion in cost savings. CEO T
Walgreens' biggest healthcare bet is floundering as it shutters 160 primary-care clinics
01:42pm, Thursday, 28'th Mar 2024
Walgreens' bet on VillageMD continues to flounder. It's exiting 160 VillageMD primary-care clinics, up from the previously planned 60.
Walgreens (WBA) is Seeing a Weak Consumer Environment
01:31pm, Thursday, 28'th Mar 2024
Jefferies has a hold rating on Walgreens (WBA). Jefferies' Brian Tanquilut discusses Walgreens most recent earnings.
Walgreens (WBA) Earnings: Turn Around Long Decline?
01:00pm, Thursday, 28'th Mar 2024
Walgreens (WBA) 2Q adjusted EPS came in at $1.20 versus an estimated $0.82 and revenue came in at $37.05B versus an estimated $36.48B. Morningstar's Kadyn Kim and Miramar Capital LLC's Max Wasserman d
Walgreens Reports Steep Loss Despite Revenue Beat on Nearly $6 Billion Impairment Charge
11:55am, Thursday, 28'th Mar 2024
Walgreens Boots Alliance (WBA) reported fiscal second-quarter revenue that beat estimates, though it posted a steep loss as it incurred billions of dollars in impairment charges.
Boots UK's sales climb on strong skincare demand
10:44am, Thursday, 28'th Mar 2024
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A)'s UK division, Boots, enjoyed a 3% rise in sales over the three months to February. This was as in-store sales climbed 4.5%, while digital sales jump
Compared to Estimates, Walgreens (WBA) Q2 Earnings: A Look at Key Metrics
10:30am, Thursday, 28'th Mar 2024
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended February 2024, it might be worth considering how some key metrics compare with Wall Str
Walgreens' quarterly results hit by $5.8B VillageMD impairment charge
10:20am, Thursday, 28'th Mar 2024
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A)'s fiscal second quarter results took a $5.8 billion hit from impairment charges on its investment in medical clinic operator VillageMD, sending its s
Cramer's Mad Dash: Walgreens
10:04am, Thursday, 28'th Mar 2024
CNBC's Jim Cramer delivers his daily Mad Dash.
